Related Experiment Video
Updated: Oct 4, 2025

Measuring the Functional Abilities of Children Aged 3-6 Years Old with Observational Methods and Computer Tools
Published on: June 20, 2020
Evidence-Informed Milestones for Developmental Surveillance Tools
Jennifer M Zubler1,2, Lisa D Wiggins1, Michelle M Macias3
1National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
Insights
The Centers for Disease Control and Prevention (CDC) revised developmental surveillance checklists with the American Academy of Pediatrics (AAP). New criteria ensure milestones are evidence-informed, reducing and replacing older checklists for better child development tracking.
Area of Science:
- Pediatrics
- Developmental Psychology
- Public Health
Background:
- Developmental surveillance is crucial for early identification of developmental delays.
- Existing checklists from the Centers for Disease Control and Prevention (CDC) required updates based on current evidence.
- The American Academy of Pediatrics (AAP) collaborated with the CDC to enhance developmental milestone tracking.
Purpose of the Study:
- To revise the CDC's developmental surveillance checklists using evidence-informed milestones.
- To establish clear age-expectations for developmental milestones, discouraging a "wait-and-see" approach.
- To support clinical judgment in developmental screening between recommended ages.
Main Methods:
- An expert working group convened by the AAP established 11 criteria for milestone selection.
- Milestones were chosen based on normative data, ease of observation, and achievement by at least 75% of children by specific ages.
- A database of normative data, screening tools, and clinical opinion informed the revisions.
Main Results:
- Revised CDC checklists feature a 26.4% reduction and 40.9% replacement of previous milestones.
- One-third of retained milestones were moved to different ages, mostly older ages.
- Approximately 80% of final milestones had supporting normative data, with gaps noted in social-emotional and cognitive domains.
Conclusions:
- The revised criteria and checklists enhance developmental surveillance and clinical judgment.
- The updates aim to improve the accuracy and timeliness of developmental screening.
- Further research is needed to address data gaps, especially in social-emotional and cognitive development.
Abstract:
The Centers for Disease Control and Prevention's (CDC) Learn the Signs. Act Early. program, funded the American Academy of Pediatrics (AAP) to convene an expert working group to revise its developmental surveillance checklists. The goals of the group were to identify evidence-informed milestones to include in CDC checklists, clarify when most children can be expected to reach a milestone (to discourage a wait-and-see approach), and support clinical judgment regarding screening between recommended ages. Subject matter experts identified by the AAP established 11 criteria for CDC milestone checklists, including using milestones most children (≥75%) would be expected to achieve by specific health supervision visit ages and those that are easily observed in natural settings. A database of normative data for individual milestones, common screening and evaluation tools, and published clinical opinion was created to inform revisions. Application of the criteria established by the AAP working group and adding milestones for the 15- and 30-month health supervision visits resulted in a 26.4% reduction and 40.9% replacement of previous CDC milestones. One third of the retained milestones were transferred to different ages; 67.7% of those transferred were moved to older ages. Approximately 80% of the final milestones had normative data from ≥1 sources. Social-emotional and cognitive milestones had the least normative data. These criteria and revised checklists can be used to support developmental surveillance, clinical judgment regarding additional developmental screening, and research in developmental surveillance processes. Gaps in developmental data were identified particularly for social-emotional and cognitive milestones.
Related Concept Videos
Introduction to Developmental Psychology
Principles of Disease Surveillance
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Steps in Outbreak Investigation

